References and Recommended Reading
Cohen R, Cervera P, Svrcek M, et al. BRAF-mutated colorectal cancer: what is the optimal strategy for treatments? Curr Treat Options in Oncol. 2017;18:9. doi:10.1007/s11864-017-0453-5.
Rosenbaum MW, Bledsoe JR, Morales-Oyarvide V, et al. PDL-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes. Mod Pathol. 2016;29:1104–12. doi:10.1038/modpathol.2016.95.
Jensen HL. BRAF refines clinical interpretation of mismatch repair deficiency in colorectal cancer. Colorectal Cancer. 2014;3:1–4. doi:10.2217/CRC.13.83.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author declares that he has no conflict of interest.
Additional information
This comment refers to the article available at http://dx.doi.org/10.1007/s11864-017-0453-5
Rights and permissions
About this article
Cite this article
Sorscher, S. Letter to the Editor: Implications of BRAF Mutations in dMMR Colorectal Cancers. Curr. Treat. Options in Oncol. 18, 57 (2017). https://doi.org/10.1007/s11864-017-0493-x
Published:
DOI: https://doi.org/10.1007/s11864-017-0493-x